Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment he has made of the level of Type (a) 1 and (b) 2 diabetes among the population of Hartlepool constituency; and what steps he is taking to (i) manage and (ii) reduce such conditions.

Diagnosed diabetes prevalence in England is taken from the Quality and Outcomes Framework (QOF) and represents all patients aged 17 and over who have been diagnosed with diabetes and included on general practice (GP) registers. Data are available by GP practices, clinical commissioning group (CCG) and for England.

Table: Estimated number of people with diabetes in Hartlepool

Source: Quality and Outcomes Framework 2014-15. NHS Digital is the trading name of the Health and Social Care Information Centre. All rights reserved.

Notes:

1. Diagnosed diabetes prevalence is not available by parliamentary constituency and has been estimated by aggregating GP practice level data where the postcode of the main practice falls within the local authority boundary.
2. The data are not split by type 1 or type 2 diabetes but it is estimated that approximately 90% of all diabetes is type 2 (source: National Diabetes Audit).

This Government is working hard to improve outcomes and quality of life for those already living with diabetes and those who will develop it in the coming years.

Preventing type 2 diabetes is a key priority. Delivery of a national diabetes prevention programme is a manifesto commitment and alongside this the mandate to the National Health Service includes goals on diabetes prevention. Healthier You: the NHS Diabetes Prevention Programme (NDPP) is the first type 2 diabetes prevention programme of its kind to be delivered at scale, nationwide. By 2020, the NDPP will be made available to up to 100,000 people at risk of diabetes each year across England. Those referred will get tailored, personalised help to reduce their risk including education on healthy eating and lifestyle and bespoke physical exercise programmes.

One of our key goals in the mandate to the NHS is a measurable reduction in variation in the management and care of people with the condition within the lifetime of this Parliament. Funding has been secured through the spending review to help achieve this and NHS England is developing a programme to ensure that those CCGs which need extra investment in this area, accompanied by sound plans for delivery, receive it.

In addition, the Clinical Commissioning Group Improvement and Assessment Framework will play a key role in delivering this as it contains two recognised evidence based measures of whether patients with diabetes are being supported to successfully manage their condition (achievement of the National Institute for Health and Care Excellence treatment targets and participation in structured education programmes).